Ng F K, Messer L B
Paediatric Dentistry, School of Dental Science, The University of Melbourne, Melbourne, Australia.
Eur Arch Paediatr Dent. 2008 Mar;9(1):4-11. doi: 10.1007/BF03321589.
Several medicaments have been used to devitalize remaining pulp or maintain pulp vitality and promote healing. Based on pulpal biocompatibility and good sealing ability, a growing interest in more biocompatible materials promotes mineral trioxide aggregate (MTA) as an alternative to traditional medicaments. Uniquely, MTA can preserve pulpal health predictably and promote healing with pulp regeneration.
Using electronic search all papers published since 1993 on the use of MTA in paediatric dentistry were identified. This paper provides a narrative review of the current literature on MTA, formocresol, ferric sulphate and calcium hydroxide with particular reference to primary teeth pulpotomy medication.
The use of formocresol or formaldehyde-based medicaments should be replaced with more biocompatible medicaments possessing antimicrobial and pulpal regenerative properties. Of the four pulpotomy medicaments discussed, mineral trioxide aggregate is recommended as the medicament of choice.
已有多种药物用于使残留牙髓失活或维持牙髓活力并促进愈合。基于牙髓生物相容性和良好的封闭能力，人们对生物相容性更高的材料兴趣日增，这促使矿物三氧化物凝聚体（MTA）成为传统药物的替代品。独特的是，MTA能够可预测地保持牙髓健康，并通过牙髓再生促进愈合。
通过电子检索，确定了自1993年以来发表的所有关于MTA在儿童牙科应用的论文。本文对当前有关MTA、甲醛甲酚、硫酸铁和氢氧化钙的文献进行叙述性综述，特别提及乳牙活髓切断术用药。
应使用具有抗菌和牙髓再生特性的生物相容性更高的药物取代甲醛甲酚或含甲醛的药物。在所讨论的四种活髓切断术用药中，推荐矿物三氧化物凝聚体作为首选药物。
Zotero 插件